Author:
Rahimi Roja,Nikfar Shekoufeh,Abdollahi Mohammad
Subject
Pharmacology,General Medicine
Reference36 articles.
1. Autoantibody profile during short-term infliximab treatment for Crohn's disease: a prospective cohort study;Atzeni;Aliment Pharmacol Ther,1995
2. Alterations in antioxidant power and levels of epidermal growth factor and nitric oxide in saliva of patients with inflammatory bowel diseases;Jahanshahi;Dig Dis Sci,2004
3. Rezaie A, Ghorbani F, Eshghtork A, et al. Alterations in salivary antioxidants, nitric oxide, and transforming growth factor-β in relation to disease activity in Crohn's disease patients. Proceedings of the Cell Signaling World 2006, Signal Transduction Pathways as therapeutic targets, Luxembourg, January 25–28; 2006.
4. Biological management of fistulizing Crihn's disease;Rezaie;Intl J Pharmacol,2005
5. Infliximab therapy in 30 patients with refractory pediatric Crihn disease with and without fistulas in The Netherlands;de Ridder;J Pediatr Gastroenterol Nutr,2004
Cited by
62 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献